Cargando…
A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization
To assess resolving-like activity by a novel chemically-modified curcumin (CMC2.24) in a “two-hit” model of diabetes-associated periodontitis. Macrophages from rats were cultured in the presence/absence of either Lipopolysaccharide (LPS, 1st hit); or advanced-glycation-end products (AGE, 2nd hit); o...
Autores principales: | Deng, Jie, Golub, Lorne M., Lee, Hsi-Ming, Bhatt, Heta-Dinesh, Johnson, Francis, Xu, Tian-min, Gu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509274/ https://www.ncbi.nlm.nih.gov/pubmed/37726411 http://dx.doi.org/10.1038/s41598-023-42848-x |
Ejemplares similares
-
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
por: Deng, Jie, et al.
Publicado: (2020) -
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
por: Bhatt, Heta Dinesh, et al.
Publicado: (2023) -
The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats
por: Bhatt, Heta Dinesh, et al.
Publicado: (2022) -
Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives
por: Antonelli, Anthony C., et al.
Publicado: (2014) -
Novel Hydrogenated Derivatives of Chemically Modified Curcumin CMC2.24 Are Potent Inhibitors of Melanogenesis in an In Vitro Model: Influence of Degree of Hydrogenation
por: Goenka, Shilpi
Publicado: (2023)